Drug Therapy (Chemotherapy)

Subscribe to Selected New Research on Drug Therapy

116907 relevant articles (11386 outcomes, 15973 trials/studies) found for this Therapy

Also Known As:

Chemotherapy; Pharmacotherapy; Therapy, Drug; Drug Therapies; Pharmacotherapies; Chemotherapies; Therapies, Drug

Relationship Network

Therapy Context: Research Results

Experts

1.	Hortobagyi, Gabriel N: 55 articles (09/2008 - 06/2002)
2.	Markman, Maurie: 34 articles (04/2008 - 02/2002)
3.	Pusztai, Lajos: 31 articles (03/2008 - 11/2002)
4.	Lyman, Gary H: 30 articles (05/2008 - 04/2002)
5.	Buzdar, Aman U: 29 articles (09/2008 - 04/2002)
6.	Bokemeyer, C: 29 articles (09/2008 - 01/2000)
7.	Monden, Morito: 24 articles (05/2008 - 09/2002)
8.	Buchholz, Thomas A: 24 articles (02/2008 - 06/2002)
9.	Longhi, Alessandra: 24 articles (07/2007 - 01/2002)
10.	Bacci, Gaetano: 24 articles (07/2007 - 01/2002)

Related Diseases

1.	Neoplasms (Cancer) 11/15/1992 - "The following conclusions were drawn from the CWS-81 study: (1) intensive chemotherapy (VACA for 35 weeks) provides long-term control for most patients with Stage I-II disease; (2) patients with primary unresectable tumors (i.e., Stage III) who achieve complete remission with chemotherapy alone have the same prognosis as patients with postoperative disease of Stages I and II; (3) tumor size and the degree of tumor regression after primary chemotherapy influence outcome and thus can be used as a basis for risk-adapted therapy." 04/01/1991 - "These results suggest that chemotherapy can be administered during pregnancy, even during the first trimester, because it is not hazardous to the fetus; nevertheless, this study is inadequate in size to exclude the possibility of teratogenesis, and more reports are necessary to define the best treatment from cancer during pregnancy." 11/01/1990 - "From maturing data in retrospective reviews, preliminary data from prospective trials, and recent well-conducted animal studies, chemotherapy and hormonal deprivation appear most effective when tumor volumes are the smallest" 01/01/2008 - "Large clinical trial networks and development of systematic research in clinical practice settings, such as that featured by the National Cancer Institute for cancer chemotherapy, would greatly accelerate the progress in incorporating new, as well as existing, agents into the best treatment strategies" 01/01/2008 - "The best results were reported in patients who had had cytoreductive surgery for primary tumor, radiofrequency ablation and chemotherapy (42)" Order ALL the reference details at left...
2.	Neoplasm Metastasis (Metastasis) 05/01/1998 - "Nevertheless, this technique seems to be able to yield the best results in: fetal malformations; calculating the volumes of normal and diseased organs; the follow-up of masses treated with irradiation/chemotherapy or with alcohol or chemoembolization; the spatial reconstruction of extensive lesions; the detection of small lesions (metastases); the study of some complex functions such as cardiac valve dynamics" 01/01/2008 - "Chemotherapy was most effective for the patients who had metastases in cervical and/or celiac lymph nodes (IV subgroup)" 02/01/2007 - "The expected overall survival rate of patients with RFA for unresectable or non-resected colorectal liver metastasis improved in comparison with the survival rate reported following the natural course (best supportive care) or chemotherapy" 09/15/2003 - "The risk of death was found to be correlated with the presence of metastases in the liver (P = 0.02) or lung pleura (P = 0.04) at the time of the diagnosis of CM. CONCLUSIONS: Sequential combination radiotherapy and vinca alkaloid-based chemotherapy appear to be the most beneficial treatment modality" 11/01/1999 - "Most notably, 3 of 8 patients with metabolically active lesions who were reexamined after chemotherapy treatment clearly showed improvement: the initial surrounding hot spots had disappeared in 2 of them, and had significantly decreased in 1. PET may prove valuable in assessing the efficacy of chemotherapy by showing the disappearance of metabolic activity and may also be useful for timely detection of relapses and metastases" Order ALL the reference details at left...
3.	Breast Neoplasms (Breast Cancer) 10/01/1995 - "To make legitimate the wide adoption of the strategy involving primary chemotherapy, most breast cancer specialists correctly advocate that the initial promising results be validated through classic randomized trials" 04/01/2005 - "The TXL weekly regimen seems to be very effective in regressing breast tumors and can be given safely in the outpatient setting with an extremely high utility profile as neoadjuvant chemotherapy as well." 01/01/2000 - "Patients with metastatic breast cancer in complete remission are the ones most likely to have an improved outcome with subsequent high-dose chemotherapy and autologous peripheral blood stem cell transplantation (HDC-PBSCT)" 02/01/1996 - "Infusional ECarboF is a highly active, well-tolerated, outpatient regimen effective against advanced/metastatic breast cancer and now warrants evaluation against conventional chemotherapy in high-risk early breast cancer." 10/01/1995 - "Adjuvant therapy with either chemotherapy or hormonal therapy offers statistically significant benefits for most subsets of women with breast cancer that in many cases outweigh the risks of treatment, but the potential benefit will vary from patient to patient and by modality of therapy" Order ALL the reference details at left...
4.	Carcinoma (Carcinomatosis) 10/01/2006 - "Chemotherapy may be more effective in highly proliferative ovarian carcinomas--a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol)." 04/01/1999 - "CONCLUSIONS: The results of the current study indicate that a weekly PFB/ME neoadjuvant chemotherapy regimen is highly effective for the treatment of patients with oral carcinoma" 08/01/1998 - "In small controlled trials, systemic chemotherapy has improved survival and quality of life of patients with advanced gastric carcinoma when compared with best supportive care" 06/01/1993 - "However, current studies with conventional chemotherapy, radiation and surgery are likely to impart at best a modest to moderate improvement in the treatment of esophageal carcinoma" 07/01/2004 - "PURPOSE: Radiotherapy -/+ chemotherapy is the first-line treatment for carcinoma of the anal canal in most oncology institutions" Order ALL the reference details at left...
5.	Lymphoma (Lymphomas) 09/01/2007 - "BACKGROUND: In recent decades, following the introduction of effective chemotherapy, the prognosis of children with leukaemia and lymphoma has dramatically improved, but data reflecting further possible improvement achieved in the 1990s are scarce" 05/01/2006 - "Median survival of affected patients has improved considerably with the use of highly active anti-retroviral therapy directed against human immunodeficiency virus, along with multi-agent chemotherapy, and outcome of such patients now approaches that of human immunodeficiency virus-negative patients with aggressive lymphoma" 09/01/2005 - "Although most primary cardiac malignant lymphomas are associated with a poor prognosis, the patient was treated successfully with chemotherapy." 12/01/2003 - "diagnosis of the lymphoma can be difficult but is necessary so that these patients do not undergo highly aggressive surgical treatment instead of chemotherapy, which currently produces the best results" 06/01/2003 - "Lymphomas are highly sensitive to chemotherapy and radiotherapy, and the recent developments in treatment have considerably improved clinical outcome" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Cisplatin (Platino)
2.	Doxorubicin (Adriamycin)
3.	Fluorouracil (Carac)
4.	Cyclophosphamide (Cytoxan)
5.	Platinum
6.	Paclitaxel (Taxol)
7.	Etoposide (VP 16)
8.	Vincristine (Oncovin)
9.	Carboplatin (JM8)
10.	Methotrexate (Mexate)

Related Therapies and Procedures

1.	Bone Marrow Transplantation (Transplantation, Bone Marrow)
2.	Immunotherapy
3.	Stem Cell Transplantation
4.	Transplants (Transplant)
5.	Transplantation (Transplant Recipients)

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 18530 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>